Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance

INTRODUCTION: This long-term post-marketing surveillance (SAPPHIRE) collected information on the safety and effectiveness of canagliflozin (approved dose 100 mg) prescribed to patients with type 2 diabetes mellitus (T2DM) in real-world practice in Japan. METHODS: Patients with T2DM who were prescrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Nobuya, Nangaku, Masaomi, Sakata, Yasushi, Sasaki, Kazuyo, Mori-Anai, Kazumi, Iwasaki, Tomohisa, Hamada, Koume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799573/
https://www.ncbi.nlm.nih.gov/pubmed/34853985
http://dx.doi.org/10.1007/s12325-021-01984-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799573/
https://www.ncbi.nlm.nih.gov/pubmed/34853985
http://dx.doi.org/10.1007/s12325-021-01984-4

Ejemplares similares